Market Overview:
MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Ocular Implants Market, The Global Ocular Implants Market size was valued at around USD 15.78 billion in 2024 and is projected to reach USD 22.6 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.2% during the forecast period, i.e., 2025-30. Various factors are attributed to the growth of the market like growth in automobile production, growing focus on lightweight sustainable materials, rising demand for luxury customized interiors, increasing focus on safety standards, and the adoption of Advanced Driver Assistance Systems (ADAS). The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Ocular Implants Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.
Industry Outlook Forecasts:
- Forecast Period: 2025-2030
- Market Size in 2024: USD 15.78 billion
- CAGR (2025-2030): 6.2%
Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/ocular-implants-market.html
Global Ocular Implants Market Segmentation Breakdown:
- By Implant Type
- Intraocular Lenses (IOL)- Market Size Forecast 2020-2030, USD Million
- Aspheric IOLs- Market Size Forecast 2020-2030, USD Million
- Toric IOLs- Market Size Forecast 2020-2030, USD Million
- Multifocal IOLs- Market Size Forecast 2020-2030, USD Million
- Anterior chamber IOLs- Market Size Forecast 2020-2030, USD Million
- Others- Market Size Forecast 2020-2030, USD Million
- Corneal Implants- Market Size Forecast 2020-2030, USD Million
- Glaucoma Implants- Market Size Forecast 2020-2030, USD Million
- Orbital Implants- Market Size Forecast 2020-2030, USD Million
- Ocular prosthesis- Market Size Forecast 2020-2030, USD Million
- Others- Market Size Forecast 2020-2030, USD Million
- Intraocular Lenses (IOL)- Market Size Forecast 2020-2030, USD Million
With roughly 45% of the market proportion, the Intraocular Lenses segment dominates the Global Ocular Implants Market.
- By Application
- Glaucoma Surgery- Market Size Forecast 2020-2030, USD Million
- Oculoplasty- Market Size Forecast 2020-2030, USD Million
- Drug Delivery- Market Size Forecast 2020-2030, USD Million
- Age-Related Macular Degeneration (AMD)- Market Size Forecast 2020-2030, USD Million
- Aesthetic purpose- Market Size Forecast 2020-2030, USD Million
- Others- Market Size Forecast 2020-2030, USD Million
The market leader for ophthalmic surgery is the Glaucoma surgery segment holding approximately 30% share. One of the leading reasons for blindness globally is glaucoma, a group of eye disorders that harm the optic nerve.
- By End User
- Hospitals- Market Size Forecast 2020-2030, USD Million
- Clinics- Market Size Forecast 2020-2030, USD Million
- Specialty Eye Institutes- Market Size Forecast 2020-2030, USD Million
Geographical Growth Insights:
- By Region
- North America
- South America
- Europe
- The Middle East Africa
- Asia-Pacific
The market for ocular implants is dominated by the North American region. Approximately 40% share of the global market for ocular implants is currently held by North America.
MarkNtel Advisors Highlights Key Market Drivers for Ocular Implants Market:
Rising Prevalence of Eye Disorders – One major factor propelling the global market for ocular implants is the increasing incidence of eye disorders. The World Health Organization estimates that at least 2.2 billion people worldwide suffer from a visual impairment with more than 1 billion of these cases being avoidable or going untreated. Cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration are the primary reasons for vision loss particularly in the aged population. For example, Glaucoma affects approximately 80 million people globally and is anticipated to affect over 111 million by 2040. Furthermore, approximately one-third of people with diabetes increase diabetic retinopathy and by 2030 there will be 643 million diabetics globally.
Effective treatment options along with intraocular lenses, glaucoma drainage devices, and retinal implants are in extra demand due to the rise in eye-related problems. By enhancing patient outcomes by vision recovery intraocular pressure management and the delivery of targeted drug treatments the growing use of ocular implants is driving market expansion.
A Comprehensive Analysis of Leading Companies in Global Ocular Implants Market
Alcon, Bausch Health Companies, Inc., Carl Zeiss Meditec Ag, Johnson Johnson, Hoya Corporation, Staar Surgical, Morcher Gmbh, Glaukos Corporation, Abbvie Inc., Second Sight Medical Products Inc., Nidek Co., Ltd., FCI Ophthalmics, Network Medical Products Ltd., Gulden Ophthalmics, Orbtex, and Others
Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/ocular-implants-market.html
Global Ocular Implants Industry Recent Development:
- April 2024: Carl Zeiss Meditec AG completed its acquisition of the Dutch Ophthalmic Research Center (D.O.R.C.), enhancing its ophthalmic portfolio and digital workflow solutions to drive innovation and expand its global presence in eye care.
- March 2024: STAAR Surgical announced the sale of over three million Implantable Collamer® Lenses (ICLs) globally, highlighting the success of its EVO ICL™ technology in providing innovative, minimally invasive vision correction for myopia, astigmatism, and presbyopia.
What are the growth Opportunity driving the Global Ocular Implants Market?
Rising Prevalence of Eye Disorders – One major factor propelling the global market for ocular implants is the increasing incidence of eye disorders. The World Health Organization estimates that at least 2.2 billion people worldwide suffer from a visual impairment with more than 1 billion of these cases being avoidable or going untreated. Cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration are the primary reasons for vision loss particularly in the aged population. For example, Glaucoma affects approximately 80 million people globally and is anticipated to affect over 111 million by 2040. Furthermore, approximately one-third of people with diabetes increase diabetic retinopathy and by 2030 there will be 643 million diabetics globally.
Effective treatment options along with intraocular lenses, glaucoma drainage devices, and retinal implants are in extra demand due to the rise in eye-related problems. By enhancing patient outcomes by vision recovery intraocular pressure management and the delivery of targeted drug treatments the growing use of ocular implants is driving market expansion.
“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”
Key Advantages of the Report by MarkNtel Advisors:
Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key subsegments, benefiting both market leaders and new entrants.
Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.
Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.
Note: If you need additional information not included in the report, we can customize it to suit your requirements.
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/ocular-implants-market.html
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative quantitative research company, strive to deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
More Research Studies:
- The Global Organ-on-Chip Marketsize was valued at around USD 126 million in 2024 and is projected to reach USD 950 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 40% during the forecast period (2025-30).
- The Global ESG Reporting Software Marketsize was valued at around USD 0.95 billion in 2024 and is projected to reach USD 2.6 billion by 2030. Along with this, the market is estimated to grow at a CAGR of 16.2% during the forecast period, i.e., 2025-30.
- The Global Mushroom Market size was valued at around USD 64 billionin 2024 and is projected to reach USD 99 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.2% during the forecast period, i.e., 2025-30.
Media Contact:
Company Name: MarkNtel Advisors
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Email: sales@marknteladvisors.com
Phone: +1 628 895 8081, +91 120 4278433
Website: www.marknteladvisors.com/
